Related Experiment Video
Updated: Oct 17, 2025

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
Staphylococcus pettenkoferi Bacteremia in an American Intensive Care Unit
Cameron Strong1,2, Michael Cosiano1, Melanie Cabezas1
1Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
Abstract:
Coagulase-negative staphylococci (CoNS) are considered the most common cause of nosocomial bloodstream infections; yet, these species are frequently designated as contaminants in the absence of systemic signs and symptoms of infection. Immunocompromised patients or those with prosthetic devices are at increased risk for clinically significant bacteremia. With the advent of matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) in clinical practice, there has been improved specificity of CoNS isolate identification and further elucidation of underrecognized pathogenic species. Staphylococcus pettenkoferi was a novel CoNS species first identified in 2002 and thought to be misdiagnosed as other CoNS due to limitations in biochemical identification. There is increasing identification of S. pettenkoferi isolates; however, there are limited case reports of clinically significant S. pettenkoferi bacteremia and no reported cases within the United States. We present the first known case of S. pettenkoferi from an American intensive care unit.
Insights
Coagulase-negative staphylococci cause many hospital infections but are often dismissed as contaminants. This report details the first U.S. intensive care unit case of bacteremia caused by the underrecognized pathogen *Staphylococcus pettenkoferi*.
Area of Science:
- Clinical microbiology and infectious diseases
- Medical diagnostics and technology
Background:
- Coagulase-negative staphylococci (CoNS) are a leading cause of hospital-acquired bloodstream infections.
- CoNS are often misidentified or considered contaminants, particularly in patients without clear infection signs.
- Advances in matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) enhance species identification accuracy.
Observation:
- *Staphylococcus pettenkoferi*, identified in 2002, is an underrecognized CoNS species.
- Previous identification limitations led to potential misdiagnosis of *S. pettenkoferi* as other CoNS.
- There is a growing number of identified *S. pettenkoferi* isolates, but limited clinical case reports exist.
Findings:
- This study reports the first documented case of *Staphylococcus pettenkoferi* bacteremia in an American intensive care unit.
- The case highlights the potential for *S. pettenkoferi* to cause clinically significant infections, even in the U.S.
- Improved diagnostic methods like MALDI-TOF MS are crucial for identifying such underrecognized pathogens.
Implications:
- Clinicians should consider *S. pettenkoferi* as a potential pathogen in bloodstream infections, especially in at-risk populations.
- Accurate identification of CoNS species is vital for appropriate patient management and infection control.
- Further research is needed to understand the full clinical significance and epidemiology of *S. pettenkoferi*.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Pyelonephritis II: Diagnostic Studies and Management
Endocarditis I: Introduction

